Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

A multicenter phase II trial to determine the safety and efficacy of combination therapy with denileukin diftitox and cyclophosphamide, doxorubicin, vincristine and prednisone in untreated peripheral T-cell lymphoma: the CONCEPT study.

Foss FM, Sjak-Shie N, Goy A, Jacobsen E, Advani R, Smith MR, Komrokji R, Pendergrass K, Bolejack V.

Leuk Lymphoma. 2013 Jul;54(7):1373-9. doi: 10.3109/10428194.2012.742521. Epub 2013 Jan 29.

PMID:
23278639
2.

LAGlambda-1: a clinically relevant drug resistant human multiple myeloma tumor murine model that enables rapid evaluation of treatments for multiple myeloma.

Campbell RA, Manyak SJ, Yang HH, Sjak-Shie NN, Chen H, Gui D, Popoviciu L, Wang C, Gordon M, Pang S, Bonavida B, Said J, Berenson JR.

Int J Oncol. 2006 Jun;28(6):1409-17.

PMID:
16685443
3.

The proteasome inhibitor PS-341 markedly enhances sensitivity of multiple myeloma tumor cells to chemotherapeutic agents.

Ma MH, Yang HH, Parker K, Manyak S, Friedman JM, Altamirano C, Wu ZQ, Borad MJ, Frantzen M, Roussos E, Neeser J, Mikail A, Adams J, Sjak-Shie N, Vescio RA, Berenson JR.

Clin Cancer Res. 2003 Mar;9(3):1136-44.

4.

Identification of polymorphisms of the IkappaBalpha gene associated with an increased risk of multiple myeloma.

Parker KM, Ma MH, Manyak S, Altamirano CV, Tang YM, Frantzen M, Mikail A, Roussos E, Sjak-Shie N, Vescio RA, Berenson JR.

Cancer Genet Cytogenet. 2002 Aug;137(1):43-8.

PMID:
12377412
5.

Human herpesvirus 8 open reading frame 26 and open reading frame 65 sequences from multiple myeloma patients: a shared pattern not found in Kaposi's sarcoma or primary effusion lymphoma.

Ma HJ, Sjak-Shie NN, Vescio RA, Kaminsky M, Mikail A, Pold M, Parker K, Beksac M, Belson D, Moss TJ, Wu CH, Zhou J, Zhang L, Chen G, Said JW, Berenson JR.

Clin Cancer Res. 2000 Nov;6(11):4226-33.

6.

The role of human and viral cytokines in the pathogenesis of multiple myeloma.

Berenson JR, Sjak-Shie NN, Vescio RA.

Semin Cancer Biol. 2000 Oct;10(5):383-91. Review.

PMID:
11100886
7.

Recent advances in multiple myeloma.

Sjak-Shie NN, Vescio RA, Berenson JR.

Curr Opin Hematol. 2000 Jul;7(4):241-6. Review.

PMID:
10882180
8.

The role of human herpesvirus-8 in the pathogenesis of multiple myeloma.

Sjak-Shie NN, Vescio RA, Berenson JR.

Hematol Oncol Clin North Am. 1999 Dec;13(6):1159-67. Review.

PMID:
10626142
9.

HHV-8 infection and multiple myeloma.

Sjak-Shie NN, Vescio RA, Berenson JR.

J Leukoc Biol. 1999 Aug;66(2):357-60.

PMID:
10449181
11.

Aprotinin inhibits urokinase but not tissue-type plasminogen activator.

Lottenberg R, Sjak-Shie N, Fazleabas AT, Roberts RM.

Thromb Res. 1988 Mar 15;49(6):549-56.

PMID:
2455360

Supplemental Content

Loading ...
Support Center